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This report dwribes clinic& morphologic mtd hisUo& findings 
at ttewww late (rattee 1.6 to 24.1 months Iswee 8.2 manlhsl) 
alto, dbi&lly succ&fuI curunary ballwn angioplas~y In LO 
wtients with caraiw analwlsst~ reskn&. ClInIcal evldence of 
&ncuis uccurred ib 14 patien~~70%), including 6 palitnts wilb 
sudden curcmary death. OPtheZOpaUrnts, 14(70%) had B cardiac 
cause of dtath and 6 06%) bad .a nuncardiac ause of dealh. 
Two ntaJor subgroups of hirtdoglc findings were observed: 1) 
intimd prdiferation (WI), and 2) atberuxkrulic plaque only 
(40%). Oflhe right sites with atheru&mUc plague only, six were 
eccentric leoions and two were concentric I&us. No morpholqir 
evidence al previws sutgioplnsty inJury (cm&s, breaks, teprs) WPI 
observed in the eighl prlkitb wlth atherot&mtlc plaque unly. 
Pmpxed mechsnlsmp for the dwebpment of lntlmal pmlifw 
ntlon involve the reaction nf smooth musk &Is and platelets, 
whereas ekwtlc recoil of overstntdted rrronlric or umxntric 
slbemxterotic ltsions reprewn(8 the most likely ex@mUlan for 
the findings in the latter subgruttp. On the hasis ufUxe#e morpba- 
k&c findings st angioplaoty resknusfs sites, speclfie Uvalment 
strategies for restenwis alter tornnsry atiery balluutt nnghtpla~ly 
are pmposod. 
fJ Anl Cdl Cwdiol3991;,,:58&,0B, 
Since its introduction in 1977 (I). corunary balloon angio- 
plasty has become widely accepted as a nonsurgica! form of 
therapy for acutely or chronically obstructed coronary ar- 
teries. Despite the widespread use of coronary balloon 
angioplasiy. advances in angioplasty technology, improve- 
ments in operator techniques and 290% primary success 
rates in dilatim, restenosis 81 the angioplasty site is the 
major problem limiting the long-term efficacy of this proce- 
dure. The frequency of restenosis ranges from 17% to 47%. 
depending on variations in definitions of restenosis: clinical, 
angiographic, physiologic. anatomic and statistical (Z-10). 
Several presious stndirs have been conducted lo defer- 
mine vwiow fncrors rhar mighr predispose m or be associ- 
arid whh resrenosis: I) ana:ographic-hemodynamic factors 
(for example, number of angiopiasty sites. pre- and postdi- 
latiun diameter, changes in transstenotic pressure gradients, 
lesion chancteristics [diffuse, long, eccentric, calcified]). the 
presence or absence of intimal flaps or dissection; 21 clinical 
factors (for example, gender, presence or absence of unsta- 
ble angina pectoris, diabetes mellitus, smoking); and 3) 
technical factors (far example. number of balloo~inflations. 
duration and pressure of balloon inflations. balluonlvessel 
size ratio). To date. no single factor factors have provided 
a predictable profile fur coronary angioplasty restenosis. 
This report describes clinical. morphologic and histologic 
changes at necropsy late (range I.6 to 24.1 months) after 
clinically successful coronary balloon angioplasty in 20 
patients with or without clinical symptoms of restenasis. 
This rcpu~ also reviews the necropsy findings in 41 previ- 
ously reported patients with coronary angiaplasty restenosir 
lesions (I l-25). 
Methods 
Cardiovascular Pathulcgy Registu accw.iun. Between 
September 1982 and June 1990. the heart from 20 patients 
with previous coronary balloon angioplasty procedures was 
entered into the Cardiovascular Pathology Registry. Hearts 
were obtained from I I hospitals in seven states. Gross and 
histologic examinations were evaluated independently by 
the local hospital pathologist or medical examiner and all 
hearts and histology slides were reexamined by one of us 
(B.F.W.). If the m&r epicardial coronary arterks had been 
sectioned before submission of the specimen, all glass his- 
tology slides (regular and specialized stains). paraffin blocks 
and wet tissue were obtained for complete coronary analy- 
sis. 
Medical records includina results of cardiac catheteriza- 
tion, coronary angiogtuphy-and balloon angioplasty were 
reviewed for each patient. If insufficient information was 
available to localize the angioplasty site. coronary angio- 
grams were reviewed. Coronary balloon angioplarty proce- 
dures were performed between 1978 and 1989. 
Morphologii localization of the angioplasty site. The or. 
tery and site of previous balloon angioplasty were identified 
from the angioplasty procedure report. In local cases. the 
coronary artery tree was perfoseb with IO% formalin at 
100 mm Hg pressure for 24 b before coronary artery sectton- 
ing. The artery subjected to angioplacty was excised from 
the heart (intact vessel if previously uncut or in piecer if 
previously sectioned into transverse sections) and radio- 
graphed For calcific deposits. If moderate to severe amounts 
of calcific deposits were identified, the artery or arterial 
regments were decalcified. The study vessel was then seri- 
ally cut into transverse cross sections from its origin to it, 
most distal point. Each coronary artery segment was placed 
in sequentially numbered cassettes and processed for his- 
tologic sectioning. The transverse coronary artery segments 
ranged in length From 3 to 5 mm. The area of previous 
angioplasty was serially step-sectioned to localize the pre- 
cise area or areas of previous angiaplasty injury and avoid 
missing any areas of focal intimal proliferation. Each coro- 
nary section was stained with hematoxylin-eorin. trichrome. 
elastic or an elastic-trichrome stain to properly identify 
coronary media and various types of luminal narrowing. In 
submitted eases in which previously sectioned coronary 
artery segme~s were removed, the corresoondinr! glass 
histology &ions were incorporated into the &dy& fitbe 
area of angioplasty had been previously sectioned. the 
accompanying parafiin block WE serially sectioned as JUSI 
described. 
From the 20 coronorv ortcrier studied, 26 coronary 
segments were cut and stained histolo&ally (three wins 
each). and 20 angioplasty sites From these arteries were 
serially sectioned, yielding 8 to I2 additional sections per 
artery. Percent cross-sectional area luminal narrowing by 
atherosclerotic plaque or intimal proliferation. or barb. was 
histologically determined by using the internal elastic mem- 
brane as the outer horder of the true coronary artery lumen. 
Luminai area reductions were classified into four subgroups: 
0% to 25%. 26% to 50%. 51% to 75% and 76% to ItN%. 
Classiialiaa of awntti versus coronth bkms. The 
residual coronary lumen at the angioplasty rite was classified 
as concentric or eccemic. If atherorcierotic plaque was 
distributed along the entire circumference of the artery, the 
cross-sectional coronary anery lumen was located centrally 
and was termed “concentric.” If atherosclerotic plaque 
failed to involve the entire coronary artery circumference. 
leaving a variable arc OF disease-free wall. the residual 
cross-scclionat lumen was termed “eccentric.” The site of 
previous angioplasty was classified as concentric or eccen- 
tric based on the initial atherosclerotic plaque diswibution 
and not on any superimposed intimal fibrous proliferation 
tissue or thrombur. Old underlying atherosclerotic plaque 
was clearly discernable from new or superimposed intimal 
proliferation tissue. or both, by the use of specialized 
histologic stains. 
ReSUltS 
Clinical Duro (Tub/e I) 
Clinical course. Four cf rhe 20 patients undergoing core. 
nary balloon angioplasty >M days b&ore death were previ- 
ously reponed (26.27). All pocedures were clinically SW 
cessfol in that symptoms of myocardial &hernia were 
relieved and final diameter reduction at the angioplasty rite 
was ~30% @utging from luminal irregularities to 30%). The 
interval from balloon angioplasty to morphologic examina- 
non ranged from 1.6 months to 24.1 months Waagc 8.2). 
Founeea patients had restenosis before :2 months. live had 
restenosia between 12 and 24 months and one oat&t was 
sludied at 24.1 months. Clinical symptoms of resteoosis 
occurred in I6 patients (80%) and 4 (2tI%) had no clinical 
evidence of restetwsis. Ten paiinIs W’6) with clinical 
symploms had had repeat coronary angiogmphy to docu- 
ment recurrent luminat narrowing at the previous aneio- 
plasty site. Patients with clinical evidence o~restenosishad 
a shorter imerval from angioplasty to de& compared with 
those without clinical symptoms t7.U versus 13.1 months, 
p < 0.05). 
MedieatiwsaflnasgiqU&. Each ofthe 20 patients had 
same type of pharmacologic therapy after angioplasty: ni- 
trates. beta-adrenergic blockers, calcium channel blockers, 
aspirin. dypyridamole, warfarin or stemkts. Five patients 
used aspmn alone; the remaining I5 patients used two or 
more drugs No specific correlation erilred benwm the 
innrwl uf rewmnosis and r/w ape ofpharmmologic rheropy 
employed. Two patients were treated with warfarin and one 
patient received prednisow (IO mglday) over a I month 
p&d. 
Modeofdeatb. Ofthe 20 patients, 14(70%) had acard~ac 
crwse of death: 2 (10%) had &rrent angioaand subsequent 
fatal acme mvccardial infarction. 6 (30%) had sudden core- 
oary death I? with preceding angina) and 6 00%) had 
recurrent enema and underwent coronary anery bypass 
surgery and died shortly thereaFter. The remaining six pa- 
tienIb (30%) had a noncardiac cause OF death: three had 
neoplaslic disease. two were auto accident victims and ale 
had a fatal stmke. Of the six palien% with a noncardiac 
cause uf death. four had o-a clinical evidence of myocardial 
ischemia and IWO had recurrent angina pctaris. 
Nrcropsy Dora (Table 2) 
Of the 20 conxtary arteries examined. gross evidence of 
the angioplasty site was present in I4 (70%. all of which had 
“whitish” material w the tuminal surface corresponding to 
inumal probferation. In the remaining six arteries (36%). no 
gross evidence of previous angioplasty was identified. These 
angioplasty sites appeared as typical atherosclerotic plaque. 
Eccenlric and tea&k lesions. Among the 20 b&on 
angioplasty sites, the plaque was concentric in IO (50%) and 
eccentnc in IO (.W%l. Correlation of the interval of resten~ 
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in the timing of restenosis: concentric 1.6 to 20 months 
(avera8e 8.3); eccentric 2 to 24.1 months (average 8.21. 
Comparing various intervals of restenosis also failed to 
disclose any significant differences in concentric versus 
eccentric plaque-<6 months: I .6 to 5 months (average 3.7). 
2 to 5.5 months (average 3.9): 6 to 12 months: 6.8 months: 
7.4 months; >I2 months: 17.2 to 20 months Iaverage 18.2). 
12.1 to 24.1 months laveraee 16.91. resoectivelv. 71~s. 
Restenosis in eccentric lesions was similar in frequency 
whetherthe interval ofrestenosis was <6 monthsor >I year 
after balloon angioplasty. 
Type of lesion al the restenasis oile (Table 2, Fig. I to 61. 
Histologic analysis of the angioplasty sites disclosed that 
intimal proliferation was responsible for the restenosis in Ii 
patient~(60%) (Fig. I to 4 and 61. Among the I? sites with 
intimal proliferation. tissue was distributed circumferemially 
(concentrically) in 8 (67%) and focally (eccentrically) m 4 
(33%). Of the I2 sites with intimal proliferation. Y (75%1 had 
some evidence of previous intimal (Patient 13) or intimal- 
medial (Patient 7) “tears.” “cracks” or “breaks.” 
Histologic analysis of the remaining 8 angioplasty bites 
(46%) disclosed typical atherosclerotic plaque (Patients 3 to 
5. IO. I I. and I4 t016) (Fig. 5 and 6). Ofthe& eight sites. six 
were eccentric atherosclerotic lesions with a variab!e wc of 
disease-free or nearly disease-free wdl (Fig. 4 and 5). None 
of these eight rites had evidence of previous angioplarty 
Injury (crack. break. tears) or healed modification of previ- 
ous injury. The atherosclerotic &we was uniformly con- 
sistent without histologic evidence of a new immature lumi- 
nal layer. The plaque was uniformly densely fibrotic with 
occasional calcitic deposits. Thus. no evidence of new or 
accelerated atherosclerotic plaque was observed as these 
eight angiopiasty sites. The arc of disease-free wall COD 
tained medial layers of normal thickness without evidence of 
scar or at:ophy. 
lntimal proliferation producing luminal narrowing at the 
angioplasly Gte occurring at I .6 months after angioplasly 
was histologically similar to the intimal proliferation occur- 
ring up to I4 and I7 months alter angioplasty (Fig. I to 4 and 
6). At 20 and 24.1 months after angioplasty, the intimal 
proliferation lesion contained focal calcitic deposits and 
lipid depoats. Histologic comparison of intimal fibrous 
proliferation in patients using various medications after 
angtoplos!y failed to disclose any significant differences in 
the lesions. The single patient receiving a short course of 
steroid therapy after angioplasty also had intimal prolifen- 
lion without distinct histologic features from those in the 
remaining It patients with iniimal proliferation without 
steroid use. 
Figure L Ilop). Sites of hallwn angio- 
plasty reswnotis showing iminal fi- 
brous pmhferalion (IFP) of variable 
degree. A, Patient I. Mild concenlric 
inlimal fibrous proliferation is present 
af 1.6 months aflcr qioplasty. B, Pa- 
tient 2. Eccenlric inlimal fibrous pmlif- 
eralion is present at 2 months. C, Pa- 
tient 6. lmimal Bbrour pmliferadon is 
present in the right coronary atiery at 
3.7 mombr. D. Patient 12. lntimal fi- 
bmus pmliferalion is present 11 5.5 
months. Magnification xl2 (A and 8). 
x4 ICI. x8 IDI. all reduced by 25%: 
elarric-trichrome slain). AP = alhcro- 
sclerotic plaque: IEM = internal elas. 
dc membrane: L = lumen. Reproduced 
from Wailer et al. 091 with permission. 
Figure 2 (right). Patient 7. lntimal h- 
bmus proliferation (IFP) al the site of 
balloon angiaplasly in the proximal left 
anterior descending coronary artery 
4.1 months after dilation. Arrows indi- 
tale previous dilation cracks. M&i. 
cadon xI0. reduced by 46%: cIr.sIic. 
trichrome slain. Abbreviations as in 
Figure I. Reproduced from Wailer e! 
al. ,271. 
with P cardiac IWWS ,I nuncurdioc WI,SY 4 drolli. In 
paliers with clinical evidence of rcstenozis (angina. myo- 
cardial infarction or sudden death). ths idma pro%ation 
was histologically similar to intimal proliferation lesions m 
palients without evidence of ischemia. Quatitatively. the 
amount of intimal proliferation appeared grea!er at anpio- 
pkwy siles with evidence of previous intimal-medal tears 
~forexarnple. Patient 7) compared with ler,ion~ with evtdence 
of intimal injury only (for example, Wtienr 13). 
The purpose of this study was to detenttine the status 
of restenosis sites after p&our coronary balloon angio- 
plasly. Morphologic and histologic obseraetions nt the re- 
stenosis sites permit separation of the patients into two 
distinct subgroups: I) intimal proliferation with or without 
pmlilzrJrion Magnik&m X IO. reduced by 147% elastic-dchmmr 
and hcmatoxylin-eminrtainr. Abbreviationasiniigure I.XeprwJuccd 
from Walk et al. (29) with pemwsion. 
evidence of healed angmplasty injury: and 2) atherosclerotic 
plaque without evidence of previous dilation injury (Fig. 6 
and 7). 
Fiure 4. Sites al coronary ungiopleny rertenorir in four padenrs. 
A. Paicnt IO. Atherorclemfic plaque LAPI with no momhologie 
evidence of previous ballwn angioplasly and no intimal fibrous prolif. 
eration ,IFP, ISO days afler rucccsrful b.3llc.a” angmp1arty. Nxe me 
eccentric lumen &I. B. Patient 13. Intnmal fibrous m&feradon at 6.8 
months. Minimal proliferation coats a previously’minimally dilated 
vcsscl wilhruue~cialinlimaliniurvonlv.C. Patient 17. lntimalfibrous 
Inlimal proliieration. In the present study. 60% of re- 
stenosis lesions had intimal proliferation. The proliferation 
was histologically similar despite differences in the interval 
of restenosib (early versus law). type of postangioplasty 
medical therapy (nitrates versus hec+adrenergic or calcium 
channel blockers versus aspirin), artery subjected lo angio- 
plasty. presence or absence of recurrent myccardial ische- 
mia or type of death (cardiac versus noncardiac). The 
amount of proliferdlion tissue appeared grew. .I in lrsions 
with evidence of previous inlimal-medial angioplasly injury 
compared with lesions with intimel injury only. 
711~ moxr widely arcqpad r,rrov for r/w developmen, of 
.jibrocellulur inrbaul prolifcmrion involves responses from 
damaged vessel endothelium and media (2.4-1.10). Major 
participants in this response appear 10 be smooth muscle 
cells in the media and diseased intima and platelets. With 
plaque disruption. localized deposition of platelets occurs 
with subsequent release of thromboxane A!. further plalekt 
deposition and release of plarelelderived growth factor. 
Vessel endothelium also releases endothelial and hbrablast 
Figure 5. Slter of previous balloon 
angioplarty showing no indmal fi- 
brow pmliferatian and no evidence 
of previous ballaon injury ,crackr. 
breaks. ,ears, or healed lesion. In- 
stead. each is an eccenlric alhem- 
sclerotic plaque wilh a variable arc of 
direarc.fi&or nearly disease-free 
wall. Elastic recoil of Ihe over- 
stretched eccentric wall is ,he likely 
mechanism ofrestenosis m Lhese pa 
den% Note the media, thickness lar- 
r”ws) is normal in the eccentric wall. 
A, Palien, 5.8. Patien, II. C. Palien, 
14. D. Patient IS. E, Padem 16. Pa. 
,ien,s I,, IS and I6 had clinical rymp 
,“mS of restcnosis. Magnification 
x10, reduced by 30% elas,ic-,ri- 
chrome stains. Reproduced from 
Wailer et al. (1% with pemir&m. 
Figure 6Ku4toml. Frcque,$y oltwotypcscdm,enos~r lesions een 
growth factors. This process appears t” result in migration. 
a, necropsy. Kepmduccd trmn wauer et a,. ,B, wlln pemnrrmn. 
proliferation and a&ion of <he vessel wall smomhmwle 
cells with fihrocellular tissue accumularion. 
A review of previously published repons (11-Z) describ- 
ing necropsy findings late after coronary balloon angioplasry 
discloses 41 necr”psy patients wilh 44 lesions (Table 3). In 
29 lesions (69%). the angioplasty site contained various 
amounls of imimai proliferation. The inlerval from anpi* 
plasty 10 death ranged fmm 2 months 10 2 years 8 monrhs 
(Table 3). 
Athemxlemtic plaques without intimal fibrous prolifera- 
lion. In the present study. R restenosis sites l4O%l had 
atherosclerotic plaque only-without superimposed intimal 
fibmcellular prolifer&“. without evidence of previous a”- 
gioplasly injury and without evidence of newly developing 
atherosclerotic plaque. Six of the eight patients in this 
rubgroup had chmcal evidence of myocardial ischemia. Of 
the eight late angioplasty lesions. SW. were eccentric and IWO 
intimai Fibrotm 
PrOiileration 
No Morphologic Evidence of injury 
With AthwoQciwotic Plaque Only 
were concentric. The arc of disease-free wall in the six 
eccentric lesions had histologically normal-appearing media 
without atrophy M scar. In contrast. the media of the 
diseased wail segments were atrophied and focally scarred. 
This observation suggests that disease-free wail segments 
may be dynamic segments reacting to various mechanical. 
neurogenic or vasoactive rtimuii (that is, capable of stretch 
acd elastic recoil). 
parims cm be explained in at least two ways: I) stretching 
of diseased wall (concentric lesions) or disease-free wall 
feccenttic iesionsl during the initial angioplasty procedure 
with subsequent elasric recoil (restenosir); and 2) progres- 
sion of atherosclerotic disease (“accelerated atherosc!ero. 
sis”) (Fig. 8). We were one of the earliest groups to suggest 
that gradual elastic recoil of overstretched vessel wall may 
represent an important subgroup of restenosis lesions after 
previous successful balloon angioplasty. 



































































coronary balloon angioplasty sites studied at necropsy (I I- cialed. Pomble explanation for long-ten recoil of over- 
25). about 33% of the sites were described as showing itrerchcd eccenmic regmenis involve recovery from tempo- 
“athemsclerofic plaque only” (Table 3). The specific type of rary or permanent injury of medial mwtb muscle cells. 
coronary artery lumen wa% not provided in most of these Temporary dysfunction (“stunned smoo!h muscle cells”) 
studies (I l-25). over a period of weeks to months may eventually regain 
Elarriz recoil oJiur onnioplarr~. Although elastic recoil function, thereby selling the stage for late recoil. Con- 
shortly after balloon angioplasly is B generally well recog- versely, acute injury of the smooth muscle cells during 
nized mechcnism of abrupt narrowmg. chronic elastic recoil dilatmn may eventually result in replacement rather than 
as a mechamsm of late luminal narrowing is not well appre- repair of these cells. Replacement with normal-functioning 
Intervention wp of Vessel Wall 
Figure9. Diagram showing wrious interventional devices and tech- 
niques for delayicr :i preventing angioptasty resvnosis. The use of 
the devices and techniques depends in pan on the anatomic sub- 
straw nf r.%cnosis. Reprodoccd from Wailer ct al, (29) with 
permisnon. 
smooth muscle cells over a period of weeks to months 
permits the possibility of recoil on a late basis. 
Accelerrrriun or progression of othrmsclrmfic plaque. 
The absence of morphologic signs of previous balloon an- 
gioplasty at necmpsy in patients with restenosis also may be 
interpreted as indicating “acceleration” or “progression” of 
underlying atherosclerotic plaque. Two histologic features in 
the present study indicate that this is an unlikely expkwa- 
tion: I) atherosclerotic plaque is densely fibrotic with focal 
calcific deposits, indicating a very mature atherosclerotic 
lesion: and 2) the inner (luminal) layers of the atherosclerotic 
plaque are histologically similar to the outer layers of the 
plaque (that is. no evidence of “new” versus “old” plaque). 
It is conceivable that many months or years after balloon 
angioplasty. intirnal proliferation tissue “changes.” **con. 
verts” or “degenerates” to typical atherosclerotic plaque by 
incorporation of lipid. In our two oldest reFteno?is lesions. 
calcific deposits were noted in the intimal probferanon 
tissue. In one case. lipid accumulatioli had occurred. The 
possibility that mural thrombus becomes incorporated into 
the underlying plaque and later progesses IC arherosclerorls 
also is unlikely in that none of the earlier angioplasty snes 
(2.7 to 3.4 months) with plaque only had any residual or 
partial mural thrombus. 
Conlirmation of necropsy restenosis findings in the living 
patient with angioplasty r&au&. One of rhe new mterven- 
tional devices used in the treatment of obslrucred coronary 
arteries is the Simpson atherectomy de&e. This device 
alters luminal obstruction by removal of obstructing material 
(6). Frequently. the atherectomy device has been used to 
treat balloon angioplasty restenosis lesions. Tissue removed 
from angioplasty restenosis sites falls into three caregories 
(Fig. 6): I) intimal proliferation; 2) atherosclerotic plaque 
with or without thrombus; and 3) thrombus only (281. lmimal 
proliferation tissue removed in the living patient is grossly 
and histologically identical to angiaplasty restenosis tissue 
observed in patients at necropsy. Atheroscleroric plaque 
removed from restenosis sites may correlate with the second 
group of restenosis lesions described in the present repon. 
namely, eccentric or concentric atherosclerotic plaque with- 
out intimrd proliferation. The initial angioplasty mechanism 
in this insrance would include inadequate or super6cial 
dilation of the lesion or eccentric or concentric vessel wall 
stretching, or both. Thus. atherectomy samples obtained 
from living patients with angioplasty rertenosis are identical 
to restenosis tissue found in patients at necropsy. The 
frequency of intimal proliferation obtained from atherec- 
tomy coronary restenosis sites is slightly less than that 
reported in the presenr study. 
Implkalkm of mcaphutugic 6ndiigs relevant to the therapy 
of angioplssty r&en& Istons. Treatment strategies for 
balloon angioplasty restenosis depend primarily on the mor- 
oholonic-histoloxic response at the anqioolasty site. If the 
Lion-consists Of inti&d proliferation~tis~ue.~various me- 
chanical, pharmacologic or immunologic approaches may be 
undertaken (Fig. 9). Alternatively. if the restenosis lesion 
remesents recoil ofa” overstretched arc ofdisease-free wall. 
other treatment strategies including thermal dilarioo (“pyre- 
plasty”) and “anti-recoil” pharmacologic therapy may he 
useful (6-P). 
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